Bangkok, April 27, 2015 – Zuellig Pharma Thailand has successfully entered into an agreement with AstraZeneca Thailand to provide contract sales and marketing services nationwide for its antihypertensive products in public hospitals, private hospitals and drugstores channel.
“AstraZeneca are pleased to enter into this commercial partnership for our anti-hypertensive portfolio. Zuellig Pharma has a strong commercial reputation in the market and we are very confident that they will help to get these important medicines in the hands of more physicians to help more patients.”
“We are extremely excited to support AstraZeneca with our commercial capabilities and expertise” added Yves Hermes, Chief Executive, Zuellig Pharma Thailand & Indochina. “Outsourcing sales and marketing services to expert companies like Zuellig Pharma for some products enables AstraZeneca to fully focus on its core products and competencies while minimizing cost. We believe that many Research Based Pharmaceutical companies will follow the leadership of AstraZeneca in searching for outside expertise along the value chain.”
The new collaboration in Thailand will further strengthen the mutually fruitful partnership between AstraZeneca and Zuellig Pharma in the Asia region.